Advances in PET/CT Imaging for Breast Cancer

被引：7

作者：

de Jong, Dorine ^{[1
]}

Desperito, Elise ^{[2
]}

Al Feghali, Karine A. ^{[3
]}

Dercle, Laurent ^{[2
]}

Seban, Romain-David ^{[4
,5
]}

Das, Jeeban P. ^{[6
]}

Ma, Hong ^{[2
]}

Sajan, Abin ^{[2
]}

Braumuller, Brian ^{[2
]}

Prendergast, Conor ^{[2
]}

Liou, Connie ^{[2
]}

Deng, Aileen ^{[7
]}

Roa, Tina ^{[2
]}

Yeh, Randy ^{[6
]}

Girard, Antoine ^{[8
]}

Salvatore, Mary M. ^{[2
]}

Capaccione, Kathleen M. ^{[2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA

[2] Columbia Univ, Dept Radiol, Irving Med Ctr, New York, NY 10032 USA

[3] RefleXion Med Inc, Hayward, CA 94545 USA

[4] Inst Curie, Dept Nucl Med & Endocrine Oncol, F-92210 St Cloud, France

[5] Paris Sci & Lettres PSL Res Univ, Inst Curie, Lab Translat Imaging Oncol, F-91401 Orsay, France

[6] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA

[7] Novant Hlth, Dept Hematol & Oncol, 170 Med Pk Rd, Mooresville, NC 28117 USA

[8] Univ Rennes 1, Ctr Eugene Marquis, Dept Nucl Med, F-35000 Rennes, France

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 13期

关键词：

breast cancer; triple negative breast cancer (TNBC); F-18-FDG; PET radiotracers; GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITORS; FIBROBLAST ACTIVATION PROTEIN; TISSUE FACTOR EXPRESSION; ANTIBODY-DRUG CONJUGATE; DIFFERENTIAL EXPRESSION; DOUBLE-BLIND; FACTOR-VIIA; IMMUNO-PET; MONOCLONAL-ANTIBODY;

D O I：

10.3390/jcm12134537

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of F-18-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient's specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis.

引用

下载

页数：24

共 50 条

[31] Recent advances in cardiac PET and PET/CT myocardial perfusion imaging
Heller, Gary V.
Calnon, Dennis
Dorbala, Sharmila
JOURNAL OF NUCLEAR CARDIOLOGY, 2009, 16 (06) : 962 - 969
[32] Advances in rubidium PET and integrated imaging with CT angiography
Smith M.F.
Current Cardiology Reports, 2008, 10 (2) : 135 - 141
[33] PET/CT and breast cancer subtypes
Laura Gilardi
Marco Colleoni
Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1301 - 1303
[34] PET/CT in Metastatic Breast Cancer
不详
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 32N - 32N
[35] PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer
Lei, Lei
Wang, Xiaojia
Chen, Zhanhong
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (02): : 377 - 382
[36] The Role of PET/CT in Breast Cancer
Hadebe, Bawinile
Harry, Lerwine
Ebrahim, Tasmeera
Pillay, Venesen
Vorster, Mariza
DIAGNOSTICS, 2023, 13 (04)
[37] PET/CT in breast cancer: an update
Groheux, D.
Moretti, J. -L.
Giacchetti, S.
Hindie, E.
Teyton, P.
Cuvier, C.
Bousquet, G.
Misset, J. -L.
Boin, C.
Espie, M.
BULLETIN DU CANCER, 2009, 96 (11) : 1053 - 1070
[38] Staging of breast cancer with PET/CT
Moller, J. S.
Pieterse, W. H.
Du Toit, P. D.
Bonnet, S.
Diedericks, A.
Brummer, W.
SA JOURNAL OF RADIOLOGY, 2008, 12 (03): : 75 - 76
[39] The restaging of breast cancer with PET/CT
Marti, Alejandro
REVISTA COLOMBIANA DE CANCEROLOGIA, 2012, 16 (03): : 192 - 194
[40] PET/CT and breast cancer subtypes
Gilardi, Laura
Colleoni, Marco
Paganelli, Giovanni
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (09) : 1301 - 1303

← 1 2 3 4 5 →